The potential for selective cyclin-dependent kinase 4/6 inhibition in the therapy for head and neck squamous cell carcinoma

D Adkins, J Ley, J Cohen, P Oppelt - The Cancer Journal, 2022 - journals.lww.com
Preclinical data support investigation of selective CDK4/6 inhibition as a therapeutic strategy
for human papillomavirus (HPV)–unrelated head and neck squamous cell carcinoma …
被引用次数：4 相关文章

The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma.

D Adkins, J Ley, J Cohen, P Oppelt - Cancer Journal (Sudbury …, 2022 - europepmc.org
Preclinical data support investigation of selective CDK4/6 inhibition as a therapeutic strategy
for human papillomavirus (HPV)-unrelated head and neck squamous cell carcinoma …

The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma

D Adkins, J Ley, J Cohen, P Oppelt - The Cancer Journal, 2022 - journals.lww.com
Preclinical data support investigation of selective CDK4/6 inhibition as a therapeutic strategy
for human papillomavirus (HPV)–unrelated head and neck squamous cell carcinoma …

The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma

D Adkins, J Ley, J Cohen, P Oppelt - Cancer Journal (United …, 2022 - profiles.wustl.edu
Preclinical data support investigation of selective CDK4/6 inhibition as a therapeutic strategy
for human papillomavirus (HPV)-unrelated head and neck squamous cell carcinoma …

The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma

D Adkins, J Ley, J Cohen… - … journal (Sudbury, Mass …, 2022 - pubmed.ncbi.nlm.nih.gov
Preclinical data support investigation of selective CDK4/6 inhibition as a therapeutic strategy
for human papillomavirus (HPV)-unrelated head and neck squamous cell carcinoma …